In conclusion, we report that CG is effective both in proximal tubular epithelial cells by inhibiting local RAS and TGFβ signaling activation and in fibroblasts by blocking their transition to myofibroblasts, in order to attenuate renal fibrosis in a murine model of Alport syndrome. This evidence concerns the gene TGFB1 and Alport syndrome.